Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
CNS Neurol Disord Drug Targets ; 22(7): 950-972, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-35864791

RESUMEN

Attention Deficit Hyperactivity Disorder is a neurodevelopmental disorder, which is characterised by a distinct clinical pattern of inattention, hyperactivity as well as impulsivity, which in turn interferes with the day-to-day activities of the affected individual. Although conventional allopathic medications have been found to provide symptomatic relief, they are accompanied by a plethora of side effects that overshadow and outweigh the potential therapeutic benefits. Hence, various alternative approaches in the management of Attention Deficit Hyperactivity Disorder (ADHD) are actively being investigated. Over the past few decades, numerous studies have been initiated and have delved into potential alternative strategies in the treatment and management of ADHD. The primary focus of this article is to discuss the etiology, pathophysiology coupled with a financial background as well as alternative strategies in the treatment and management of ADHD. A review of the literature on the clinical trialson alternative treatment approaches for ADHD showed that, plants and dietary supplements have beneficial effects on ADHD management. But in-depth studies still need to be conducted because the trials reported till now have a smaller sample size and need to be scaled up to get a broader understanding and knowledge of the potential impact of alternative forms of natural treatment on the patient population with ADHD. Also, the manufacturer of the alternative formulations needs to develop effective protocols and processes for the safe, effective, and robust manufacturing of such natural remedies, which fall in line with the expectation of the FDA to gain regulatory clearance for its manufacturing and sale, which can lead to better therapeutic outcomes in patients.


Asunto(s)
Trastorno por Déficit de Atención con Hiperactividad , Humanos , Trastorno por Déficit de Atención con Hiperactividad/tratamiento farmacológico , Suplementos Dietéticos , Conducta Impulsiva
2.
Curr Drug Discov Technol ; 19(3): e040322201773, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35249493

RESUMEN

The tropical parasitic infections account for more than 2 billion infections and cause substantial morbidity and mortality, and account for several million deaths every year. Majorly parasitic infections in humans and animals are caused by protozoa and helminths. Chronic infections in the host can cause retardation, impairment of cognitive skills, development in young children and weaken the immune system. The burden is felt to a greater extent in developing countries due to poverty, inaccessibility to medicines and resistance observed to drugs. Thus, human health continues to be severely harmed by parasitic infections. Medicinal plants have received much attention as alternative sources of drugs. Zanthoxylum genus has been used ethnobotanically as an antiparasitic agent and the phytoconstituents in Zanthoxylum, show a wide variety of chemical substances with proven pharmacological actions such as alkaloids (isoquinolines and quinolines responsible for antitumor activity, antimalarial, antioxidant and antimicrobial actions), lignans, coumarins (antibacterial, antitumour, vasodilatory and anticoagulant activities), alkamide (strong insecticidal properties, anthelminthic, antitussive and analgesic anti antimalarial property). Therefore, this article is an attempt to review the existing literature that emphasizes on potential of genus Zanthoxylum as a source of lead compounds for the treatment of parasitic diseases.


Asunto(s)
Alcaloides , Antimaláricos , Enfermedades Parasitarias , Plantas Medicinales , Zanthoxylum , Alcaloides/química , Animales , Enfermedades Parasitarias/tratamiento farmacológico , Zanthoxylum/química
3.
Chem Biol Drug Des ; 98(6): 1116-1130, 2021 12.
Artículo en Inglés | MEDLINE | ID: mdl-34626448

RESUMEN

Cancer continues to be a disease that is difficult to cure and the current therapeutic regimen is associated with severe side effects and the issue of emerging drug resistance. According to the World Health Organization fact sheet 2017, cancer is the second major cause of morbidity and death and a 70% rise in new cases is expected over the next 20 years. The quest for new anticancer chemical entities is a thrust area identified by many government agencies and industry research and development groups. Nature-derived entities have played a very important role in therapeutics especially cancer Asteraceae is a large family consisting of around 1700 genera and more than 24,000 species. Several genera belonging to this family have ethnopharmacological uses such as cytotoxicity, antidiabetic, hepatoprotective and antioxidant. This review highlights the cytotoxic potential of structurally novel flavonoids and sesquiterpenes isolated from some selected species of Asteraceae plants native to Asia, Europe, parts of Africa and America. The existing literature suggests that sesquiterpenes and flavonoids from various species of Asteraceae represent a viable class of secondary metabolites with strong cytotoxic potential. These have demonstrated potent activity in cell cycle arrest, inhibition of neoangiogenesis and induction of apoptosis. The sesquiterpenoids exhibiting potent cytotoxic activity were found to contain an α- methylene-butyrolactone conjugated with an exomethylene group and the flavonoids obtained from various plant species of Blumea suggest that a dihydroxy ring system present in structure is essential for activity. Most of the published literature contains in vitro data of extracts/secondary metabolites with very few in vivo studies. Additionally, there is dearth of knowledge on mechanisms of cytotoxic activity and molecular targets impacted by the active secondary metabolites. This review hopes to fuel interest in researchers to take up detailed investigations on these scaffolds that could contribute significantly as potential leads in anticancer drug development.


Asunto(s)
Antineoplásicos Fitogénicos/química , Antineoplásicos Fitogénicos/farmacología , Asteraceae/química , Flavonoides/farmacología , Sesquiterpenos/farmacología , Animales , Anticarcinógenos/química , Anticarcinógenos/farmacología , Flavonoides/química , Humanos , Sesquiterpenos/química
4.
Nutr Cancer ; 73(9): 1768-1779, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-32811210

RESUMEN

BACKGROUND: Newer drugs are in demand for leukemia treatment that specifically targets tumor cells without affecting normal cells. Potent cytotoxic activities have been reported from various parts of Zanthoxylum rhetsa. Thus, the present study was conducted to evaluate antileukemic potential of leaf extract of Z. rhetsa along with probable mechanism of cytotoxicity. Materials and Methods: The antiproliferative activity of the extract on leukemic cell lines was evaluated using sulforhodamine B assay. The changes in cell death profile, cell cycle, and expression levels of pro-apoptotic markers (p53, Bax, cytochrome C, caspase 3, and MMP) and antiapoptic marker (Bcl2) on Jurkat cell lines were studied using flow cytometer. Comparison of oxidative stress induced by extract on Jurkat cells and normal mouse fibroblast cells was done. DNA fragmentation was studied using gel electrophoresis. Results: The leaf extract showed concentration-dependent cytotoxicity against Jurkat cell lines majorly via apoptotic mechanism. It arrested cells at G0/G1 and S phase of cell cycle. Apoptosis was associated with increase in the expression of pro-apoptotic markers and decrease of anti-apoptotic markers. The treatment with extract selectively increased the oxidative stress in Jurkat cells and showed DNA fragmentation. Conclusion: The methanol extract of leaves of Z. rhetsa show selective cytotoxic activity on Jurkat cell lines and induced apoptosis via intrinsic pathway.


Asunto(s)
Antineoplásicos , Zanthoxylum , Animales , Antineoplásicos/farmacología , Apoptosis , Humanos , Células Jurkat , Ratones , Extractos Vegetales/farmacología
5.
AAPS PharmSciTech ; 17(3): 607-17, 2016 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-26285673

RESUMEN

Citrus auranticum and Glycyrrhiza glabra are rich in anti-oxidant polyphenols helpful in prevention of skin aging. Polyphenols have high polarity and lower skin penetration resulting in lower cutaneous delivery. The present work is attempted to develop a novel polyherbal phospholipid complex cream to improve cutaneous delivery of polyphenols for sustained anti-oxidant action. Phytochemical and in vitro anti-oxidant evaluation was done on methanolic extracts of orange peel and liquorice powder. Total phenolic content, total flavonoid content, and anti-oxidant assays were done on different ratios of orange peel and liquorice extract. Ratio 1:2 gave highest total phenolic content (TPC) (530.00 ± 1.56 mg gallic acid equivalent (GAE) g(-1) extract), total flavonoid content (TFC) (246.25 ± 1.03 mg rutin equivalent (RUE) g(-1) extract), 2,2-diphenyl-1-picrylhydrazyl (DPPH) scavenging activity (87.99 ± 0.64%), and H2O2 scavenging activity (72.47 ± 0.86%) and hence was used for formulation. Solvent evaporation method using methanol with 1:1 extract to phospholipid ratio was found to have entrapment efficiency of 93.22 ± 0.26%. Evaluation parameters like scanning electron microscopy (SEM), Fourier transform infrared spectrophotometry (FT-IR), and differential scanning calorimetry (DSC) confirmed formation of complex. The complex was formulated as oil-in-water cream and evaluated for various parameters. The optimized cream containing 1% complex was non-irritant and was found to be stable for 3-month period under conditions of stability study. Ex vivo diffusion studies showed that extract phospholipid complex cream had better retention of polyphenols in the skin when compared to conventional extract cream giving prolonged and stronger topical action. The cream had an anti-elastase activity of 28.02 ± 0.95% at concentration of 3000 µg ml(-1) (w/v). Thus, the developed safe and stable polyherbal phytophospholipid complex cream exhibited good potential as anti-aging cosmeceutical.


Asunto(s)
Citrus , Sistemas de Liberación de Medicamentos/métodos , Glycyrrhiza , Fosfolípidos/administración & dosificación , Extractos Vegetales/administración & dosificación , Envejecimiento de la Piel/efectos de los fármacos , Animales , Evaluación Preclínica de Medicamentos/métodos , Femenino , Masculino , Fosfolípidos/aislamiento & purificación , Fosfolípidos/farmacocinética , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/farmacocinética , Ratas , Ratas Wistar , Envejecimiento de la Piel/patología , Crema para la Piel/administración & dosificación , Crema para la Piel/farmacocinética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA